Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

49.81
Delayed Data
As of 4:00pm ET
 -1.46 / -2.85%
Today’s Change
38.40
Today|||52-Week Range
58.59
+18.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash21.7M16.6M65.7M63.9M
 
 
 
 
 
Short Term Investment Cash-9.0M-5.1M49.1M-1.8M
 
 
 
 
 
Cash & Short Term Investments145.2M210.1M223.7M308.7M
 
 
 
 
 
 
ReceivablesReceivables15.7M12.8M10.6M67.2M
 
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets9.7M9.2M3.5M4.5M
 
 
 
 
 
Current Assets170.6M232.2M237.8M380.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross10.2M13.1M15.1M17.5M
 
 
 
 
 
Depreciation-4.3M-5.1M-7.1M-9.1M
 
 
 
 
 
Other Assets0.000.000.0092.0K
 
 
Total Assets246.0M281.4M327.9M415.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M3.4M3.7M4.7M
 
 
 
 
 
Short Term Debt69.0K73.0K79.0K0.00
 
 
 
 
Accrued Expenses964.0K2.1M5.1M6.6M
 
 
 
 
 
Other Current Liabilities2.3M2.1M5.1M6.6M
 
 
 
 
 
Other Liabilities6.7M7.9M21.0M16.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt692.0K617.0K1.1M1.9M
 
 
 
 
 
Deferred Taxes-4.6M-8.4M-10.1M-8.4M
 
 
 
 
 
Other Liabilities1.9M1.9M1.5M593.0K
 
 
 
 
 
Total Liabilities9.9M11.4M26.2M21.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity236.2M269.9M301.7M393.7M
 
 
 
 
 
Total Shareholder Equity236.2M269.9M301.7M393.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding18.7M19.0M19.1M19.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.